Appointed Chairman and Director of Accuron Technologies in Year 2000.  He is the Chairman of the Executive Resource & Compensation Committee of the Company, and  Chairman of Singapore Aerospace Manufacturing, a subsidiary of the Company.

He is also the Chairman of Spring Singapore, Special Advisor to the Prime Minister’s Office on Economic Development, Senior Advisor to the Ministry of Trade & Industry on Science and Technology, and Chairman of the Standards, Productivity and Innovation.

He has served in public as well as private sector positions. Currently, he is Chairman of A-Bio Pharma, Ascendas Property Fund Trustee, PLE Investments Pte Ltd (an EDB Associated Company) and MTIC Holdings; and a director of United Overseas Bank and Far Eastern Bank, among others.

He was the past chairman of both the Economic & Development Board and the Agency for Science, Technology and Research (A*STAR) of Singapore.

Appointed as a Director of Accuron Technologies in 2004. He is the Chairman of the Audit Committee and Risk Committee of the Company.

Currently , he is Chairman of RSM Chio Lim, one of the leading and fastest-growing accounting and business advisory groups in Singapore. He is currently holding directorships in other companies, including SF Consulting Pte Ltd, Sunningdale Tech, Tuan Sing Holdings and Gul Technologies Singapore.

He was also the past Chairman of the Singapore Association of the Institute of Chartered Secretaries and Administrators, the President of the Singapore branch of the Institute of Chartered Management Accountants, and Council Member of the Association of Chartered Certified Accountants London.

Appointed as a Director of Accuron Technologies in 2004. He is a member of the Audit Committee and Risk Committee of the Company and a director of Dornier MedTech, a subsidiary of the Company.

He is currently the Head of Drew & Napier LLC's Intellectual Property Department and the Patent Division. He joined Drew & Napier in 1983 and became a partner in 1989. He has been a director of Drew & Napier LLC since its incorporation in 2001. He is currently holding other directorships in Freshfields Drew & Napier, Drewmarks, Patents & Designs and PT Drewmarks Konsultama.

Appointed as a Director of Accuron Technologies in 2004.

Presently, he is Chairman of Tuan Sing Holdings and Advisor to The EDB Society and Nuri Holdings (S). He is also a Director of MobileOne Ltd and Oversea-Chinese Banking Corporation.

His past experience includes President of DBS Singapore and directorships with EDB Singapore and Malaysian Ministry of Agriculture (Fisheries Department).

Appointed as a Director of Accuron Technologies in 2004. He is a member of the Executive Resource & Compensation Committee of the Company and Chairman of Dornier MedTech, a subsidiary of the Company.

A stalwart of healthcare in Singapore, Professor Tan Ser Kiat presently serves as Group Chief Executive Officer of SingHealth, a leading public healthcare group committed to medical excellence, research and teaching, and is the Chairman of Singapore Cord Blood Bank and Positron Traces.

He is also holding several directorships in public health institutions under SingHealth Group, including Aescapulus Holdings, and is a director of the Intellectual Property Office of Singapore.

Appointed as a Director of Accuron Technologies in 2004. He is also a director of Singapore Aerospace Manufacturing, a subsidiary of the Company.

He is Chairman of CapitalRetail China Trust Management and Fullerton Fund Management Company. Currently, he is also holding directorships in SIM and ST Treasury Services. He is the Commissioner of PT Bank Danamon Indonesia Tbk and a member of the Catalist Advisory Panel and Appeal Advisory Panel.